Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 2Pain 1Osteoporosis 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Radiotherapy 5Analgesia 4Zoledronic Acid 2strontium chloride 1Vitamin D 1Therapeutics 1Strontium-89 1Samarium-153 1Radiosurgery 1Radiofrequency Ablation 1Psychiatric Rehabilitation 1Prednisone 1Palliative Care 1Observation 1Nutritional Support 1Neck Dissection 1Morphine 1Mitoxantrone 1Methadone 1Mental Status and Dementia Tests 1Interviews as Topic 1Ibandronic Acid 1Glutamine 1Gemcitabine 1Fibroblast Growth Factor 7 1Fatty Acids, Omega-3 1Duloxetine Hydrochloride 1Dextromethorphan 1Counseling 1Clodronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pain × Calcium × Clear all
NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
261 enrolled 12 charts
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡